A new study validates the Sybil AI model for predicting lung cancer risk using low-dose CT in a predominantly Black cohort at an urban safety-net hospital.
Key Details
- 1Study presented at the 2025 IASLC World Conference on Lung Cancer.
- 2Validation conducted at UI Health on 2,092 baseline low-dose CT scans from 2014-2024.
- 3Cohort primarily Non-Hispanic Black (62%), with 13% Hispanic and 4% Asian.
- 4Sybil demonstrated strong Area Under the Curve (AUC): 0.94 (1 yr), 0.90 (2 yr), 0.86 (3 yr), 0.85 (4 yr), 0.80 (5 yr), 0.79 (6 yr).
- 5Results remained strong after restricting to Black participants and excluding recent diagnoses.
- 6The Sybil Implementation Consortium will advance to prospective clinical trials for clinical workflow integration.
Why It Matters
Demonstrating reliable AI performance in racially and socioeconomically diverse settings is crucial for equitable lung cancer screening. This validation may facilitate broader adoption and help address longstanding disparities in lung cancer outcomes.
Source
EurekAlert
Related News
•EurekAlert
AI-Enhanced CT Heart Fat Measurement Boosts Cardiovascular Risk Prediction
AI-derived measurement of heart fat from CT scans significantly improves long-term cardiovascular disease risk prediction.
•EurekAlert
AI Software Matches Invasive Gold Standard in Coronary Flow Assessment
AI-based FFRangio software performs comparably to invasive pressure wire methods for evaluating coronary artery disease in a major international clinical trial.
•EurekAlert
AI Model Uses Cardiac Ultrasound to Diagnose Advanced Heart Failure
Researchers have developed an AI tool that accurately diagnoses advanced heart failure using cardiac ultrasound and patient health records.